Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

Detalles Bibliográficos
Autores principales: Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321697/
https://www.ncbi.nlm.nih.gov/pubmed/32637035
http://dx.doi.org/10.18632/oncotarget.27403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321697/
https://www.ncbi.nlm.nih.gov/pubmed/32637035
http://dx.doi.org/10.18632/oncotarget.27403

Ejemplares similares